Tarsons Products Ltd

Tarsons Products Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tarsons Products Ltd

₹ 375 0.93%
28 Apr 11:38 a.m.
tarsons.com BSE: 543399 NSE: TARSONS
About

Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]

Key Points

India’s Leading Labware Company[1]
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments)

Website BSE NSE
  • Market Cap ₹ 1,996 Cr.
  • Current Price ₹ 375
  • High / Low ₹ 544 / 280
  • Stock P/E 43.6
  • Book Value ₹ 118
  • Dividend Yield 0.53 %
  • ROCE 10.2 %
  • ROE 8.62 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • The company has delivered a poor sales growth of 9.18% over past five years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 6.92% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Miscellaneous

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
70.66 84.94 68.63 71.25 61.32 82.05 62.57 66.32 61.79 86.64 64.85 80.12 76.16
37.52 40.61 37.49 38.55 34.65 42.79 41.27 40.94 38.90 52.77 47.83 56.62 48.24
Operating Profit 33.14 44.33 31.14 32.70 26.67 39.26 21.30 25.38 22.89 33.87 17.02 23.50 27.92
OPM % 46.90% 52.19% 45.37% 45.89% 43.49% 47.85% 34.04% 38.27% 37.04% 39.09% 26.25% 29.33% 36.66%
2.46 2.58 2.69 3.71 3.36 2.17 2.26 2.60 3.38 5.93 4.86 10.65 2.12
Interest 1.37 0.45 0.43 0.74 1.23 2.07 2.41 0.95 2.51 4.08 4.20 4.68 4.13
Depreciation 5.35 7.24 6.14 6.90 7.21 8.27 8.30 9.71 10.06 10.21 8.96 11.96 15.61
Profit before tax 28.88 39.22 27.26 28.77 21.59 31.09 12.85 17.32 13.70 25.51 8.72 17.51 10.30
Tax % 25.66% 24.89% 25.53% 25.44% 25.34% 26.57% 25.29% 26.10% 26.42% 26.34% 25.80% 26.21% 26.12%
21.47 29.46 20.31 21.46 16.12 22.82 9.60 12.80 10.07 18.78 6.46 12.93 7.61
EPS in Rs 4.04 5.54 3.82 4.03 3.03 4.29 1.80 2.41 1.89 3.53 1.21 2.43 1.43
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
179 176 229 301 283 277 308
107 107 125 148 153 174 205
Operating Profit 72 69 103 153 130 103 102
OPM % 40% 39% 45% 51% 46% 37% 33%
6 4 5 8 12 14 24
Interest 7 6 3 4 4 10 17
Depreciation 15 14 14 22 29 38 47
Profit before tax 56 53 92 135 109 69 62
Tax % 30% 24% 25% 25% 26% 26%
39 41 69 101 81 51 46
EPS in Rs 2,027.06 2,108.74 3,583.25 18.92 15.17 9.63 8.60
Dividend Payout % 0% 0% 0% 0% 0% 21%
Compounded Sales Growth
10 Years: %
5 Years: 9%
3 Years: 7%
TTM: 13%
Compounded Profit Growth
10 Years: %
5 Years: 6%
3 Years: -9%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -19%
1 Year: -20%
Return on Equity
10 Years: %
5 Years: 18%
3 Years: 16%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.19 0.20 0.19 11 11 11 11
Reserves 135 197 244 479 559 610 618
65 36 34 22 111 257 244
12 15 18 33 46 76 109
Total Liabilities 212 249 296 544 726 953 982
89 92 120 189 225 252 399
CWIP 7 19 22 32 119 267 217
Investments 0 0 0 0 0 0 0
116 137 153 323 382 434 366
Total Assets 212 249 296 544 726 953 982

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
51 64 68 83 76 105
-34 -26 -64 -138 -179 -296
-18 -14 -27 130 85 136
Net Cash Flow -0 25 -23 75 -18 -55

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 91 79 75 79 85 94
Inventory Days 333 365 277 478 642 528
Days Payable 14 44 35 75 54 42
Cash Conversion Cycle 409 400 317 482 672 580
Working Capital Days 160 149 108 165 205 179
ROCE % 27% 37% 35% 19% 10%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31% 47.31%
9.33% 9.90% 9.60% 9.16% 8.64% 7.85% 6.83% 8.16% 7.95% 8.04% 7.51% 9.53%
8.06% 8.13% 8.52% 8.45% 7.38% 3.15% 2.60% 0.17% 0.11% 0.21% 0.51% 0.30%
35.31% 34.67% 34.59% 35.09% 36.67% 41.68% 43.27% 44.36% 44.63% 44.45% 44.69% 42.89%
No. of Shareholders 1,12,2271,07,0111,07,9451,05,3041,07,4401,08,2361,07,5641,02,8661,05,33099,58696,92793,417

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls